Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Announcement from the extra general meeting in Misen Energy AB (publ)

The extra general meeting of Misen Energy AB (publ) ("Misen" or the "Company") was held today on 12 June 2024 and the following resolution was passed by the meeting. Approval of sale of all shares in the Company's subsidiary Misen Enterprises AB The extra general meeting resolved, in accordance with the boards' proposal, to approve the sale of all shares in the Company's subsidiary Misen Enterprises AB, reg. no. 556809-6233 (the "Subsidiary") to Breakfast Language LLC in accordance with a signed share transfer agreement. The purchase price for the shares in the Subsidiary amounts

Webstep ASA: Exercise window for share options

Oslo, 12 June 2024: With reference to the stock exchange announcement by Webstep ASA (the “Company”) of 18 November 2019, in which it was announced that Webstep ASA granted employee share options as part of the Company’s long-term incentive programme (“LTIP”).The Company will conduct a window on 20 June 2024 in which the option holders may exercise share options. The total amount of vested options is 729,786 options, of which 491,286 options are in the money as of 12 June 2024 and exercisable for the option holders.

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B23K0M20 Issuer Name CAPITA PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Schroders Plc City of registered office (if applicable) London Wall, Barbican Country of registered office (if applicable) England 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

‘Gas can accelerate the energy transition today’

At the AIEN International Energy Summit in Bangkok, Thailand, one of the panels took a look at ‘One Year Later – Is Natural Gas Still Relevant to the Energy Evolution’? Natural gas continues to be front and center in the evolution of the global energy portfolio. As countries look to their energy solutions, how does natural gas, particularly LNG, impact the security, affordability and sustainability of a robust energy future?Moderator Edward Taylor, Partner, A&O Shearman kicked off the discussion with a simple question, reflected in the session’s title: is natural gas still relevant to the

Advania further expands in the UK through the acquisition of Servium to strengthen the end-to-end offering for its customers

With the acquisition of Servium Limited (“Servium”), Advania UK will enhance its end-to-end offerings in professional services, managed services, and value-added reselling for both existing and new customers. Moreover, Advania and Servium aim to create an exceptional workplace, allowing talent from both companies to excel in a decentralized, customer-centric environment. The acquisition aligns with Advania's goal of becoming the preferred IT-services provider in Northern Europe.Key transaction highlights · Advania has acquired 100% of the shares in Servium from management and employees.

Report of payments to government agencies in 2023

Holmen is today publishing its report of payments to government agencies in accordance with Swedish law (2015:812) on the reporting of payments to government agencies. The report covers payments to authorities in Sweden in 2023 for activities in the extractive industry. The report is available as of today at www.holmen.com. For more information, please contact:Stina Sandell, Senior Vice President Sustainability and Communications, Holmen, +46 (0)73 986 51 12 This information is information that Holmen AB is obliged to make public pursuant to the Securities Markets Act. The

EQT to acquire majority position to support the growth of CluePoints, a leading provider of AI-powered software solutions used for data interrogation and analytics in clinical trials

· CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in clinical trials, designed to enable safer and more efficient processes and improving data integrity and risk compliance · As scientific breakthroughs and advancements in technology and data are accelerating healthcare innovation, the markets for RBQM and data interrogation & analytics software are expected to experience strong growth · In this highly thematic investment at the intersection of pharma, software and AI, EQT will apply its expertise investing in

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 131 – 12 JUNE 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Gasum agrees on long-term financing including extended green loan and sustainability targets

Gasum has signed a long-term financing agreement at a total of EUR 565 million with its current lenders.Nordea acted as coordinator, OP Corporate Bank as sustainability coordinator, and SEB as co-coordinator and agent of the arrangement. The financing includes a term loan and revolving credit facilities. The amount of Gasum’s green loan has been extended from EUR 152 million to 175 million. The green loan is used to finance Gasum’s strategic investments into increasing biogas production both by expanding biogas production at existing plants as well as construction of new large-scale

BioStock: BiBBInstruments’ technology gets nod in medical journal

The interest in Swedish medtech BiBBInstruments’ biopsy instrument EndoDrill is increasing as doctors evaluate it in the clinic, being called a “game-changer” within endoscopic ultrasound. Recently, the technology was also featured in a South American medical journal Revista de Gastroenterología del Perú, penned by leading specialist in the field, Dr Antonio Mendoza Ladd.Read the article at biostock.se: BiBBInstruments’ technology gets nod in medical journal - BioStock This is a press release

Pohjan Voima and Finsilva co-operate in the development of approx. 500 MW of new wind and solar power

Arise AB (publ) (“Arise”) has today, via its Finnish subsidiary Pohjan Voima, entered into a co-operation agreement with Finsilva, one of Finland’s largest landowners. The co-operation opens up opportunities for the development of new wind and solar projects, which may also include battery storage. Three of Pohjan Voima's current wind farm projects are located on land partially owned by Finsilva in Karstula, Keuruu and Parkano. In deepening their co-operation, Pohjan Voima and Finsilva have identified five new project areas, which have the conditions for the development of approximately

Turning up the heat: students compete in geothermal business challenge! Baseload Power Japan and Waseda University’s Global Management Program team up for energy and sustainability

Tokyo, Japan – Baseload Power Japan Co., Ltd., a subsidiary of Sweden-based Baseload Capital, recently co-hosted a business case competition with Waseda University's Global Management Program. The event focused on developing geothermal energy in Japan and took place at Waseda University's School of Commerce, featuring approximately 130 students from Waseda University and the Hong Kong University of Science and Technology. The competition's theme was "Enhancing Awareness and Acceptance of Geothermal Energy in Japanese Local Communities.” In the final stage, four of the 22 teams

ScandiNova joins the United Nations Global Compact

ScandiNova Group is proud to announce its participation in the United Nations Global Compact (UNGC) initiative, reinforcing the company’s commitment to sustainable and responsible business practices.“We are honored to be part of this significant global initiative. This step allows us to take greater responsibility and work more intensively towards setting the standard for sustainable and responsible business alongside the other members,” said Niklas Edling, CEO of ScandiNova Group. In the past year, ScandiNova has broadened its approach to sustainability by implementing several

ExpreS2ion CEO to BioStock: “Compelling preclinical package gives us confidence”

Based on its proprietary protein expression platform, ExpreS2ion Biotech advances its ES2B-C001 breast cancer vaccine candidate toward clinical studies. A SEK 60 million rights issue is underway to fund this pivotal step. CEO Bent U. Frandsen discussed the current development and the future plans ahead with BioStock.Read the full article at biostock.se : https://www.biostock.se/2024/06/expres2ion-ceo-compelling-preclinical-package-gives-us-confidence/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

YAZEN HEALTH RESEARCH REVEALS OVER A THIRD OF BRITS WRONGLY BELIEVE OBESITY IS A PERSONAL CHOICE

New survey uncovers widespread misunderstandings around obesity as a disease LONDON, 12th June 2024 – Despite obesity's tremendous toll on public health and the economy, myths and misconceptions persist with over one-third (37%) of Brits mistakenly viewing it as a personal choice rather than a chronic medical disease and 43% attributing obesity to laziness. This is according to striking new independent research from Yazen Health , a leading digital provider of comprehensive, medically-assisted weight loss treatment. The results highlight a concerning

Nel ASA: A fully dedicated electrolyser company

(June 12, 2024 - Oslo, Norway) Nel ASA (Nel, OSE:NEL). As of today, Nel is solely dedicated to developing and delivering world-class electrolysers to produce renewable hydrogen.“Nel has almost a century of experience developing electrolysers and has installed thousands of systems around the world. Building on our unparalleled track record, we will, from now on, spend one hundred percent of our capacity and hydrogen know-how on developing and delivering the most reliable and energy-efficient electrolysers,” says Nel’s CEO, Håkon Volldal. Nel’s CEO says this on the same day Nel’s former

Tecnotree Board of Directors approves the Long-Term Incentive (LTI) plan for 2024 -2027, additional RSUs and the issuance of shares to Tecnotree

Tecnotree Corporation Stock Exchange release 12 June 2024 at 10:00 EESTTecnotree announced today that its Board of Directors has approved the company's employee long-term incentive program for 2024-2027 (the "LTI Plan 4") designed to align the participants' focus with Tecnotree’s growth strategy and long-term success. The LTI Plan 4 includes the following instrument: Restricted Share Units (RSUs) giving a contractual right to receive shares over the next 3 year period as per an equated annual vesting schedule. LTI Plan 4 Objective The incentive plan aims to keep pace with the

DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio

COPENHAGEN, Denmark, 12 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has formally submitted applications for two additional medicines to enrich the existing portfolio with the Danish Medicines Agency under the Danish Pilot Programme for medicinal cannabis.Submission of two new applications: · FLS04, CBD-granulate · FLS05, THC-flos The applications encompass two new medicines, poised to complement the current trio of approved products (Bedrocan®, Bedica®, and Bediol®). These include a THC-dominant

Prize offered for people getting to Taylor Swift’s Liverpool concerts with Voi

Above: E-scooter rider in Liverpool, Credit: Voi People travelling to Taylor Swift’s Anfield concerts on a Voi e-bike or e-scooter are in with a chance of winning a month’s worth of free rides. Voi has launched a competition asking anyone taking one of their e-bikes or e-scooters to Swift’s concerts to send a selfie to be in the running to win a month’s pass worth £35 for 300 minutes. To enter, like, tag and share Voi's competition post on social media and comment with a selfie on a Voi e-bike or e-scooter outside the stadium to Voi on X @VoiTechnologyUK 

Senior life science and medical specialists join SmartCella’s Board of Directors

SmartCella Holding AB (“SmartCella”) held its 2024 Annual General Meeting on June 10. The company welcomed investors to its state-of-the art clinical GMP manufacturing facility in Stockholm to learn more about the progress of SmartCella during the last 12 months. In addition, the investors met and interacted with the new board members who all hold unique life science industry and medical expertise. The newly appointed Board of Directors will play a pivotal role as SmartCella embarks on its next strategic development phase.SmartCella is an innovative biotechnology company with a vision to

Kemira Oyj: Announcement of manager’s transaction; Tuija Pohjolainen-Hiltunen, President of the Industry & Water segment, has sold 8,420 Kemira shares

Kemira Oyj, Managers' transactions, June 12, 2024 at 10.00 am (EEST)Kemira Oyj: Announcement of manager’s transaction; Tuija Pohjolainen-Hiltunen, President of the Industry & Water segment, has sold 8,420 Kemira shares Kemira has received a notification from Tuija Pohjolainen-Hiltunen, President, Industry & Water segment, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below. Person subject to the notification requirementName: Tuija Pohjolainen-HiltunenPosition: Other senior

The subscription period in ExpreS2ion’s rights issue begins today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. FOR MORE INFORMATION, SEE THE SECTION IMPORTANT INFORMATION BELOW. Hørsholm, Denmark, 12 June 2024 – Today is the first day of the subscription period in ExpreS2ion Biotech Holding AB's (“ExpreS2ion” or the “Company”) rights

60,000 companies have not filed their beneficial owner details – the PRH deregisters companies that have not filed their beneficial owner details by 25 September 2024

The Finnish Patent and Registration Office (PRH), which maintains the Finnish Trade Register, will deregister companies that have not filed their beneficial owner details despite requests to do so. This week, the PRH made an entry in the Finnish Trade Register of limited liability companies and co-operatives that have not filed their beneficial owner details despite the request. These companies will be ordered into liquidation or removed from the Finnish Trade Register if they do not file their notification of beneficial owners by 25 September 2024.Deregistration will take place in October

Perpetua Medical is offered a loan facility of up to SEK 25 million

Perpetua Medical AB (publ) is offered a loan facility of up to SEK 25 million from the company’s main shareholder, Nolsterby Invest AB, to be used for financing acquisitions.The company's main shareholder, Nolsterby Invest AB, has offered a loan facility of up to SEK 25 million under the terms described below, provided that the agreement is approved by an extraordinary general meeting (EGM), to be held no later than August 31, 2024. Nolsterby Invest AB is offering this loan facility to enable the company to make its first acquisitions under the company’s new business direction, as the

There are no items matching the current filter
There are no more items matching the current filter
Back to top